Association of CYP19 and ESR1 pleiotropic genes with human longevity

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 66 A, Issue 1, 2011, Pages 51-55

  Corbo, Rosa Maria ^a,b   Ulizzi, Laura ^a   Positano, Lidia ^c   Scacchi, Renato ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b CNR   (Italy)

^c CORISA Consortium ^*  (Italy)

Author keywords

CYP19; ESR1; Longevity; Longevity fertility trade off; Polymorphism

Indexed keywords

AROMATASE; ESR1 PROTEIN, HUMAN; ESTROGEN RECEPTOR ALPHA;

AGED; ARTICLE; FEMALE; FERTILITY; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; LONGEVITY; MALE; PLEIOTROPY; STATISTICAL MODEL;

AGED; AGED, 80 AND OVER; AROMATASE; ESTROGEN RECEPTOR ALPHA; FEMALE; FERTILITY; GENETIC PLEIOTROPY; GENOTYPE; HUMANS; LOGISTIC MODELS; LONGEVITY; MALE; POLYMORPHISM, GENETIC;

EID: 79951612271     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glq160     Document Type: Article

References (43)

1. Christensen K, Johnson TE, Vaupel JW. The quest for genetic determinants of human longevity: challenges and insights. Nat Rev Genet. 2006;7:436-448. (Pubitemid 43780487)
2. Karasik D, Hannan MT, Cupples LA, Felson DT, Kiel DP. Genetic contribution to biological aging: the Framingham Study. J Gerontol A Biol Sci Med Sci. 2004;59:218-226. (Pubitemid 38375334)
3. Karasik D, Demissie S, Cupples LA, Kiel DP. Disentangling the genetic determinants of human aging: biological age as an alternative to the use of survival measures. J Gerontol A Biol Sci Med Sci. 2005;60:574-587. (Pubitemid 40847918)
4. Newman AB, Walter S, Lunetta KL, et al. A meta-analysis of four genome-wide association studies of survival to age 90 years or older: the Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium. J Gerontol A Biol Sci Med Sci. 2010;65:478-487.
5. Deroo BJ, Korach KS. Estrogen receptors and human disease. J Clin Invest. 2006;116:561-570. (Pubitemid 43326860)
6. Garcia-Segura LM, Azcoitia I, Don Carlos LL. Neuroprotection by estradiol. Prog Neurobiol. 2001;63:29-60.
7. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med. 1999;340:1801-1811. (Pubitemid 29266405)
8. Jiang M, Huhtaniemi I. Polymorphisms in androgen and estrogen receptor genes: effects on male aging. Exp Gerontol. 2004;39:1603-1611. (Pubitemid 39576132)
9. Penn DJ, Smith KR. Differential fitness costs of reproduction between the sexes. Proc Natl Acad Sci U S A. 2007;104:553-558. (Pubitemid 46123063)
10. Gagnon A, Smith KR, Tremblay M, Vézina H, Paré PP, Desjardins B. Is there a trade-off between fertility and longevity? A comparative study of women from three large historical databases accounting for mortality selection. Am J Hum Biol. 2009;21:533-540.
11. Westendorp RG, Kirkwood TB. Human longevity at the cost of reproductive success. Nature. 1998;396:743-746. (Pubitemid 29024050)
12. Korpelainen H. Fitness, reproduction and longevity among European aristocratic and rural Finnish families in the 1700s and 1800s. Proc R Soc Lond B Biol Sci. 2000;267:1765-1770.
13. Le Bourg E. Does reproduction decrease longevity in human beings? Ageing Res Rev. 2007;6:141-149. (Pubitemid 47017807)
14. Corbo RM, Ulizzi L, Piombo L, Scacchi R. Study on a possible effect of four longevity candidate genes (ACE, PON1, PPAR-γ, and APOE) on human fertility. Biogerontology. 2008;9:317-323.
15. Lio D, Candore G, Crivello A, et al. Opposite effects of interleukin 10 common gene polymorphisms in cardiovascular diseases and in successful ageing: genetic background of male centenarians is protective against coronary heart disease. J Med Genet. 2004;4:790-794. (Pubitemid 39389298)
16. Westendorp RG, van Dunne FM, Kirkwood TB, Helmerhorst FM, Huizinga TW. Optimizing human fertility and survival. Nat Med. 2001;7:873. (Pubitemid 32756403)
17. Bulun SE, Sebastian S, Takayama K, Suzuki T, Sasano H, Shozu M. The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters. J Steroid Biochem Mol Biol. 2003;86:219-224. (Pubitemid 37412560)
18. Corbo RM, Gambina G, Ulizzi L, Moretto G, Scacchi R. Genetic variation of CYP19 (aromatase) gene influences age at onset of Alzheimer's diseasein women. Dement Geriatr Cogn Disord. 2009;27:513-518.
19. Combarros O, Riancho JA, Infante J, et al. Interaction between CYP19 aromatase and butyrylcholinesterase genes increases Alzheimer's disease risk. Dement Geriatr Cogn Disord. 2005;20:153-157. (Pubitemid 41191631)
20. Gennari L, Masi L, Merlotti D, et al. A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: effects on bone metabolism. J Clin Endocr Metab. 2004;89:2803-2810. (Pubitemid 38766369)
21. Haiman CA, Stram DO, Pike MC, et al. A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort. Hum Mol Genet. 2003;12:2679-2692. (Pubitemid 37304690)
22. Huang R, Poduslo SE. CYP19 haplotypes increase risk for Alzheimer's disease. J Med Genet. 2006;43: e42.
23. Iivonen S, Corder E, Lehtovirta M, et al. Polymorphisms in the CYP19 gene confer increased risk for Alzheimer disease. Neurology. 2004;62:1170-1176. (Pubitemid 38456512)
24. Matthews J, Gustafsson JA. Estrogen signaling: a subtle balance between ER alpha and ER beta. Mol Interv. 2003;3:281-292.
25. Brandi ML, Becherini L, Gennari L, et al. Association of the estrogen receptor alpha gene polymorphisms with sporadic Alzheimer's disease. Biochem Biophys Res Commun. 1999;265:335-338.
26. Corbo RM, Gambina G, Ruggeri M, Scacchi R. Association of estrogen receptor a (ESR1) PvuII and XbaI polymorphisms with sporadic Alzheimer's disease and their effect on apolipoprotein E concentrations. Dement Geriatr Cogn Disord. 2006;22:67-72.
27. Isoe K, Ji Y, Urakami K, Adachi Y, Nakashima K. Genetic association of estrogen receptor gene polymorphisms with Alzheimer's disease. Alzheimer Res. 1997;3:195-197. (Pubitemid 27475101)
28. Corbo RM, Ulizzi L, Piombo L, Martinez-Labarga C, De Stefano GF, Scacchi R. Estrogen receptor alpha (ESR1) polymorphisms and fertility in populations with different reproductive patterns. Mol Hum Reprod. 2007;13:537-540. (Pubitemid 47241907)
29. Cresta M, Gregorio G. Il disegno dello studio LONCILE. Riv Antropol. 2001;79:11-18.
30. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.
31. Herrington DM, Howard TD, Brosnihan B, et al. Common estrogen receptor polymorphism augments effects of HRT on E-selectin but not C-reactive protein. Circulation. 2002;105:1879-1882. (Pubitemid 34437611)
32. Herrington DM, Howard TD, Hawkins GA, et al. Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease. N Engl J Med. 2002;346:967-974. (Pubitemid 34983246)
33. Maruyama H, Toji H, Harrington CR, et al. Lack of an association of estrogen receptor alpha gene polymorphisms and transcriptional activity with Alzheimer disease. Arch Neurol. 2000;57:236-240. (Pubitemid 30097192)
34. Yaich L, Dupont WD, Cavener DR, Parl FF. Analysis of the PvuII restriction fragment length polymorphism and exon structure of the estrogen receptor gene in breast cancer and peripheral blood. Cancer Res. 1992;52:77-83.
35. Haiman CA, Dossus L, Setiawan VW, et al. Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women. Cancer Res. 2007;67:1893-1897. (Pubitemid 46424203)
36. Petry CJ, Ong KK, McHelmore KF, et al. Association of aromatase (CYP19) gene variation with features of hyperandrogenism in two populations of young women. Hum Reprod. 2005;20:1837-1843. (Pubitemid 40932365)
37. Terwilliger J, Ott J. Handbook for Human Genetic Linkage. Baltimore, MD: John Hopkins University Press; 1994.
38. Capri M, Salvioli S, Monti D, et al. Human longevity within an evolutionary perspective: the peculiar paradigm of a post-reproductive genetics. Exp Gerontol. 2008;43:53-60.
39. De Rango F, Dato S, Bellizzi D, et al. A novel sampling design to explore gene-longevity associations: the ECHA study. Eur J Hum Genet. 2008;16:236-242.
40. Kjaergaard AD, Ellervik C, Tybjaerg-Hansen A, et al. Estrogen receptor alpha polymorphism and risk of cardiovascular disease, cancer, and hip fracture: cross-sectional, cohort, and case-control studies and a meta-analysis. Circulation. 2007;11:861-871. (Pubitemid 46294727)
41. Vina J, Sastre J, Pallardò FV, Gambini J, Borràs C. Modulation of longevity-associated genes by estrogens or phytoestrogens. Biol Chem. 2008;389:273-277. (Pubitemid 351329025)
42. Sundarrajan C, Liao W, Roy AC, Ng SC. Association of oestrogen receptor gene polymorphisms with outcome of ovarian stimulation in patients undergoing IVF. Mol Hum Reprod. 1999;5:797-802. (Pubitemid 29406741)
43. Kukuvitis A, Georgiou I, Bouba I, et al. Association of oestrogen receptor alpha polymorphisms and androgen receptor CAG trinucleotide repeats with male infertility: a study in 109 Greek infertile men. Int J Androl. 2002;25:149-152. (Pubitemid 34595740)